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The environment is increasingly being recognized as an important 
driver of human health and the weight of the evidence is sufficiently 
high, thus warranting timely preventative action (Diamanti-Kandarakis 
et al. 2009; President’s Cancer Panel 2010; Woodruff et al. 2008). 
However, it is a challenge to keep abreast of the deluge of scientific 
literature linking the environment to health. The volume and highly 
variable quality of data, as well as the barrage of bits and pieces of 
information, can leave the public and policy makers (and scientists) 
confused and overwhelmed as they try to grapple with the meaning 
behind the information. A perusal through PubMed on any of the hot 
topics in environ  mental health [e.g., bisphenol A, phthalates, PBDEs 
(polybrominated diphenyl ethers)] finds numerous studies on each 
topic. Each of us tries to sort through the accumulating evidence to 
understand its meaning, whether at the most personal level (e.g., should 
I give my baby water using a sippy cup made from poly  carbonate plas-
tic) to a more global level (e.g., should a pesticide be banned from use). 
Too much noise can diffuse rather than coalesce our common percep-
tion of the signal and undermine our capacity to act wisely.
Thus, reviews of scientific evidence are a critical step toward speed-
ing the incorporation of the science into action to prevent harm. 
Reviews assemble and synthesize the evidence across studies to inform 
an over  all conclusion about state-of-the-science knowledge. Simple in 
concept, but challenging in application, lessons can be learned from 
the clinical field, which has grappled with a parallel need to incorpo-
rate the meaning of the science in a systematic and timely manner into 
beneficial patient treatment decisions and prevention methods.
Historically, the clinical field relied largely on a system of expert 
reviews on which to base treatment decisions (Rennie and Chalmers 
2009). However, starting in the 1970s, the role of expert reviews began to 
be questioned for a number of reasons (e.g., potential bias of experts, time-
liness of information); this led to the development of systematic approaches 
that would use rigorous, transparent, and explicit methodology to evaluate 
a clearly formulated question. Landmark papers published in the clinical 
literature, such as Antman et al. (1992), showed that reviews based solely 
on expert opinion “did not work” and demonstrated the superiority of sys-
tematic reviews for patient outcomes (Rennie and Chalmers 2009). 
The need for a comparable approach to reviews is equally compel-
ling in the field of environmental health science because of the large 
number of studies and because they are as subject to bias as those in the 
clinical sciences. Notably, the influence of financially conflicted sources 
of funding is well recognized in the clinical world (Rennie 2010), and 
widely used examples of systems that utilize best practices for weighing 
and communicating the strength of the scientific evidence (West et al. 
2002) prohibit sponsorship by any commercial source or sources [i.e., 
Cochrane Reviews (Higgins and Green 2006)] or recommend that the 
quality of potentially conflicted evidence be downgraded when evalu-
ated [i.e., Grading of Recommendations, Assessment, Development 
and Evaluation (GRADE) (Guyatt et al. 2008)]. Similar concerns have 
been raised in the environmental health literature (President’s Cancer 
Panel 2010) and warrant similar attention. 
However, although the clinical sciences point the way, these sys-
tems are not fully transferable to environmental health science because 
of differences in the types of evidence generally available and how deci-
sions to expose populations and individuals are made. For example, in 
the clinical setting, in vivo, in vitro, and human experi  mental evidence 
combined with an 
analysis of risks 
and benefits have 
informed human 
exposure decisions 
prior to the the 
entry of the substances into the marketplace. Systematic reviews in the 
clinical sciences proceed from this evidence and context. 
In stark contrast, population exposure to exogenous substances in 
the environment typically occurs before regulatory scrutiny of a com-
pound and in the absence of risk–benefit analysis, because of the cur-
rent regulatory structure for governing manufactured chemicals. Ethical 
considerations virtually preclude experimental human data from the 
environmental health evidence stream, so we must rely on in vitro 
and in vivo studies for early warnings of adverse effects and on human 
observational studies to assess the nature and extent of the damage. 
To rapidly move the best science into improved health outcomes, 
we need to apply the pertinent lessons and embrace the continued chal-
lenges of the clinical sciences. To that end, we are collaborating with 
22 scientists and clinicians from the United States and Europe to craft 
the Navigation Guide, a systematic and transparent methodology that 
proceeds from GRADE but reflects the differences in evidence and deci-
sion contexts. Professional societies, health care organizations, govern-
ment agencies, and other potential guideline developers working with 
toxicologists can use the Navigation Guide to craft consistent and timely 
recom  menda  tions to improve patient and population health outcomes.
Finally, the science of systematic reviews in the clinical sciences 
has evolved to be a relatively well-resourced and respected academic 
field in its own right. Currently, the science of environmental health 
science review and synthesis is largely relegated to regulatory and other 
government agencies, and few resources are allocated to the science 
of interpretation. The rising prominence of the environment as a key 
determinant of health requires that we devote concordant effort to pri-
mary scientific discovery and to the building upon and synthesis of the 
research through the systematic and transparent reviews. The reviews in 
this issue of Environmental Health Perspectives are a welcome step in the 
right direction. 
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Editorial
In this issue of Environmental Health Perspectives, Feingold et al. 
(2010) propose a unique step forward for toxicology: incorporating 
infectious disease agents and theory into the toxicological paradigm.
The fields of infectious disease and toxicology intersect on many 
different levels. First, they can act concurrently, as when global bands 
of various tropical diseases widen due to increased atmospheric tem-
peratures. For example, in A Human Health Perspective on Climate 
Change, the Interagency Working Group on Climate Change and 
Health (2010) identified health effects from climate change, as well 
as the health benefits from mitigating climate change. These various 
health effects range from respiratory and cardio  vascular disease, to 
developmental and neurological disorders, to food- and waterborne 
illness, and vectorborne and zoonotic disease. It is increasingly clear 
that climate change—a marquee issue in the field of environmental 
health—and infectious disease are linked. 
Second, the two fields can also act antagonistically: For exam-
ple, the newly renewed appeals for global use of DDT (dichloro-
diphenyltrichloro  ethane) to combat malaria will pit the well-known 
hazardous effects of DDT against the scourge of malaria. In many 
countries DDT has been banned for agricultural use; it is considered 
a Class II or “moderately hazardous” pesticide by the World Health 
Organization (International Programme on Chemical Safety 2005), 
and its use is strictly limited by the 2001 Stockholm Convention. 
However, use of DDT is still permitted for vector control. This bal-
ance of risks and benefits is a conundrum for scientists and policy 
makers, but it reveals the serious issues raised when infectious disease 
and environmental health interests clash.
Third, these two disciplines can act synergistically, as in the inter-
actions between hepatitis B and aflatoxin in hepatic cancer. Both   
hepatitis B and aflatoxin are independent factors in liver cancer. 
However, when combined, they act powerfully to raise the risk of 
hepatic cancer up 
to 60 times that of 
unexposed individ-
uals (Groopman 
et al. 2005). This 
National Institute 
of Environmental Health Sciences (NIEHS)-funded research is a 
primary example of the interaction between environ  mental health and 
infectious disease and can serve as a model for future research efforts.
Supression of the immune response by polychlorinated biphenyls 
(PCBs) was first shown in mice and nonhuman primates. Recently, in 
another example of concurrent interaction, NIEHS-funded studies led 
by Philippe Grandjean have shown that perinatal and developmental 
exposure to PCBs adversely impact immune responses to childhood 
vaccinations (Heilmann et al. 2006, 2010).
We have an opportunity at the NIEHS to embrace this new para-
digm. As we have shown with our investment in research into the 
aflatoxin–hepatitis B and PCB–vaccine interactions, the NIEHS has a 
track record that could promote a wider interest in this field of inquiry.
Ideas like these are supported not only at the institute level but 
also throughout the National Institutes of Health (NIH). Recently, 
NIH director Francis Collins (2010b) wrote, “NIH can play a major 
role in ramping up the discovery of novel targets in both pathogen 
and host and work to facilitate advances in prevention . . . .” Collins 
(2010a) also wrote, “the best outcomes are generally when you don’t 
have walls between parts of the organization that prevent people from 
learning from each other.” 
A recent presentation at the NIEHS outlined a vision for the 
institute that included the infectious disease and environmental 
health intersection within the context of the rapid evolution in 
the field of environmental health, specifically in epigenetics. As we 
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recognize that our old assumptions about toxi  cants and how they 
affect our bodies are being changed by modern science (e.g., exposure 
effects are not only dose dependent but are also affected by both time 
and context), the field of environmental health is moving fast and the 
NIEHS needs to be at the front with innovative, bold ideas so we can 
participate and lead with the best science possible. The idea of incor-
porating infectious disease into the toxicological paradigm is exactly 
the kind of pioneering concept that can take environmental health to 
the next level. 
The NIEHS Office of the Director will be working with division 
leaders to develop an initiative on infectious disease and environ-
mental health—to incorporate infectious disease into the toxicological 
paradigm. We look forward to the possibilities to strengthen the field 
of environmental health science.
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